These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 1425297)

  • 1. [New perspectives in immunotherapy: adhesion molecules, superantigens, heat-shock proteins and cytokine antagonists].
    Gause A; Sahin U; Pfreundschuh M
    Dtsch Med Wochenschr; 1992 Nov; 117(46):1764-73. PubMed ID: 1425297
    [No Abstract]   [Full Text] [Related]  

  • 2. [The current outlook in the therapy of autoimmune diseases].
    Sebastiani GD; Passiu G
    Ann Ital Med Int; 1992; 7(2):95-101. PubMed ID: 1467130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New immunologic treatment of rheumatoid arthritis].
    Sany J
    Rev Rhum Ed Fr; 1993 Mar; 60(3):229-39. PubMed ID: 8293009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New strategies in the immunotherapy of autoimmune diseases].
    Lorenz HM; Geiler T
    Dtsch Med Wochenschr; 2001 Sep; 126(37):1023-8. PubMed ID: 11555778
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunotherapy in non-allergic diseases].
    Español T
    Allergol Immunopathol (Madr); 2000; 28(3):107-9. PubMed ID: 10867379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prospects of immunotherapy in rheumatoid arthritis].
    Lotz M
    Rev Rhum Ed Fr; 1993 Jan; 60(1):3-9. PubMed ID: 8242024
    [No Abstract]   [Full Text] [Related]  

  • 7. [TNF inhibitors: a new therapeutic perspective in chronic inflammatory diseases in rheumatology?].
    Fenner H
    Z Rheumatol; 1995; 54(3):158-64. PubMed ID: 7660686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor immunotherapy].
    Błoński JZ; Warzocha K
    Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biological therapy in rheumatoid arthritis].
    Abraham Simón J
    Rev Invest Clin; 2001; 53(5):452-9. PubMed ID: 11795111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological evaluation of cytokine and anticytokine immunotherapy in vivo: what have we learnt?
    Jorgensen C; Apparailly F; Sany J
    Ann Rheum Dis; 1999 Mar; 58(3):136-41. PubMed ID: 10364909
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmunity induction by human T cell leukemia virus type 1 in transgenic mice that develop chronic inflammatory arthropathy resembling rheumatoid arthritis in humans.
    Iwakura Y; Saijo S; Kioka Y; Nakayama-Yamada J; Itagaki K; Tosu M; Asano M; Kanai Y; Kakimoto K
    J Immunol; 1995 Aug; 155(3):1588-98. PubMed ID: 7636219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy in sepsis syndrome].
    Schellekens JF; van Deventer SJ
    Ned Tijdschr Geneeskd; 1992 May; 136(22):1050-4. PubMed ID: 1603159
    [No Abstract]   [Full Text] [Related]  

  • 14. [New approaches to biological immunomodulation therapy of rheumatoid arthritis: neutralization of basic cytokines].
    Lukina GV; Sigidin IaA; Skurkovich SV; Skurkovich BS
    Ter Arkh; 1998; 70(5):32-7. PubMed ID: 9644739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New trends in immunotherapy of rheumatoid arthritis].
    Todesco S; Fiocco U; Cozzi L
    Clin Ter; 1991 Dec 15-31; 139(5-6):257-63. PubMed ID: 1802515
    [No Abstract]   [Full Text] [Related]  

  • 16. Biologic interventions in rheumatoid arthritis.
    Cush JJ; Kavanaugh AF
    Rheum Dis Clin North Am; 1995 Aug; 21(3):797-816. PubMed ID: 8619100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-splenocytes from non-obese diabetic mice binding to xenogeneic pancreatic beta-cells in vitro. Implication of the alpha/beta T-cell receptor and of major histocompatibility complex class II molecules from target cells.
    Martignat L; Feve B; Ouary M; Pogu S; Charbonnel B; Saï P
    J Autoimmun; 1993 Dec; 6(6):753-69. PubMed ID: 8155255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of autoimmune diseases.
    Bach JF
    Recenti Prog Med; 1988; 79(7-8):343-50. PubMed ID: 3059421
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunotherapy in rheumatoid arthritis; current status].
    Breedveld FC; van de Putte LB
    Ned Tijdschr Geneeskd; 1996 Jun; 140(24):1255-9. PubMed ID: 8700279
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.